Stealth RNAi™ siRNA Negative Control, Med GC
Mechanism of action of siRNA molecules. SiRNA molecules are... | Download Scientific Diagram
Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA | Molecular Pharmaceutics
siRNAs and shRNAs: Tools for Protein Knockdown by Gene Silencing
Team:Lethbridge HS/Design - 2021.igem.org
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing - ScienceDirect
Frontiers | Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools
Development of therapeutic-grade small interfering RNAs by chemical engineering
Frontiers | siRNA-Finder (si-Fi) Software for RNAi-Target Design and Off-Target Prediction
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
In Vivo RNAi | Thermo Fisher Scientific - US
RNAトランスフェクションのためのガイドラインと最適化方法 - Learning at the Bench
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications
Precise and efficient siRNA design: a key point in competent gene silencing | Cancer Gene Therapy
In Vivo RNAi | Thermo Fisher Scientific - US
In Vivo RNAi | Thermo Fisher Scientific - US
Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence | PNAS
Small interfering RNA - Wikipedia
Precise and efficient siRNA design: a key point in competent gene silencing | Cancer Gene Therapy
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease | Cell Death & Disease
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
Advances in RNAi Tools and Technologies
siRNAとmiRNAの違いは何？RNA干渉(RNAi)に関する基礎知識 - Learning at the Bench
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates: Molecular Therapy
Successful RNA Interference Experiments in Difficult-to-Transfect Cell Lines
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids
